HIVE Blockchain Technologies (CVE:HIV) Upgraded by Northland Capmk to Strong-Buy

Northland Capmk upgraded shares of HIVE Blockchain Technologies (CVE:HIV) to a strong-buy rating in a research note released on Thursday, Zacks.com reports.

Separately, HC Wainwright raised shares of HIVE Blockchain Technologies from a hold rating to a strong-buy rating in a research report on Thursday, August 15th.

HIVE Blockchain Technologies Price Performance

HIVE Blockchain Technologies (CVE:HIV) last issued its quarterly earnings data on Monday, August 12th. The company reported C($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.10) by C($0.01). The business had revenue of C$44.11 million for the quarter, compared to the consensus estimate of C$43.64 million.

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.